News on CIRION BioPharma Research Incorporated from BioPortfolio.com http://www.BioPortfolio.com Consolidated CIRION BioPharma Research Incorporated news from BioPortfolio.com Wed, 10 Feb 2010 10:45:38 GMT en News and FDA Updates for IMS Health (NYSE:RX), Incyte (Nasdaq:INCY), Ligand (NASDAQ:LGND)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040265&HITNO=0&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040265&THISHREF=http://c.moreover.com/click/here.pl%3fz2538680663%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040265&HITNO=0&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040265&THISHREF=http://c.moreover.com/click/here.pl%3fz2538680663%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Chronicle: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038960&HITNO=1&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038960&THISHREF=http://c.moreover.com/click/here.pl%3fz2537852243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038960&HITNO=1&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038960&THISHREF=http://c.moreover.com/click/here.pl%3fz2537852243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038931&HITNO=2&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038931&THISHREF=http://c.moreover.com/click/here.pl%3fz2537838958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038931&HITNO=2&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038931&THISHREF=http://c.moreover.com/click/here.pl%3fz2537838958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation For Duchenne Muscular Dystrohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040716&HITNO=3&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040716&THISHREF=http://c.moreover.com/click/here.pl%3fz2538850339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040716&HITNO=3&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040716&THISHREF=http://c.moreover.com/click/here.pl%3fz2538850339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCafepharma: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035246&HITNO=4&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035246&THISHREF=http://c.moreover.com/click/here.pl%3fz2536164492%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035246&HITNO=4&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035246&THISHREF=http://c.moreover.com/click/here.pl%3fz2536164492%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Ligand Pharmaceuticals Incorporated Q4 2009 Earnings Call Transcripthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036985&HITNO=5&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036985&THISHREF=http://c.moreover.com/click/here.pl%3fz2536855824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036985&HITNO=5&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036985&THISHREF=http://c.moreover.com/click/here.pl%3fz2536855824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSeeking Alpha: Ligand Pharmaceuticals (LGND) Tops Q4 EPS by 3c on Strong Revenues; Guides for 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035713&HITNO=6&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035713&THISHREF=http://c.moreover.com/click/here.pl%3fz2536339539%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035713&HITNO=6&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035713&THISHREF=http://c.moreover.com/click/here.pl%3fz2536339539%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035289&HITNO=7&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035289&THISHREF=http://c.moreover.com/click/here.pl%3fz2536185463%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035289&HITNO=7&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035289&THISHREF=http://c.moreover.com/click/here.pl%3fz2536185463%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035267&HITNO=8&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035267&THISHREF=http://c.moreover.com/click/here.pl%3fz2536176351%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035267&HITNO=8&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035267&THISHREF=http://c.moreover.com/click/here.pl%3fz2536176351%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034925&HITNO=9&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034925&THISHREF=http://c.moreover.com/click/here.pl%3fz2536050493%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034925&HITNO=9&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034925&THISHREF=http://c.moreover.com/click/here.pl%3fz2536050493%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Genta commences Phase 2 trial of tesetaxel on first subjecthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034650&HITNO=10&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034650&THISHREF=http://c.moreover.com/click/here.pl%3fz2535909558%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034650&HITNO=10&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034650&THISHREF=http://c.moreover.com/click/here.pl%3fz2535909558%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Genta commences treatment in tesetaxel Phase 2 trial for advanced melanomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033220&HITNO=11&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033220&THISHREF=http://c.moreover.com/click/here.pl%3fz2535076243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033220&HITNO=11&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033220&THISHREF=http://c.moreover.com/click/here.pl%3fz2535076243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: YM BioSciences reports second quarter 2010 operational and financial resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035612&HITNO=12&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035612&THISHREF=http://c.moreover.com/click/here.pl%3fz2536294543%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035612&HITNO=12&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035612&THISHREF=http://c.moreover.com/click/here.pl%3fz2536294543%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Canopus BioPharma, Inc.-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034073&HITNO=13&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034073&THISHREF=http://c.moreover.com/click/here.pl%3fz2535600918%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034073&HITNO=13&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034073&THISHREF=http://c.moreover.com/click/here.pl%3fz2535600918%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Can-Fite BioPharma, Ltd.-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034072&HITNO=14&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034072&THISHREF=http://c.moreover.com/click/here.pl%3fz2535600626%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034072&HITNO=14&MSIZE=845&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CIRION%20BioPharma%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034072&THISHREF=http://c.moreover.com/click/here.pl%3fz2535600626%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: